Meta-analysis · 2001
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment
Hróbjartsson A, Gøtzsche PC
The New England Journal of Medicine, 2001 · PMID 11372012
In short
The influential skeptical analysis: pooling trials with both placebo and no-treatment arms found little evidence of clinically important placebo effects outside subjective outcomes such as pain.
- Study type
- Meta-analysis
- Published
- The New England Journal of Medicine, 2001
- Topics
- Skeptical evidence, Methodology, Effect size
is the placebo effect real or an artifact?
Mostly modest, on the strictest test — when 114 trials were analysed with genuine no-treatment arms, placebos showed no significant effect on binary or objective outcomes, and only a modest effect on subjective outcomes such as pain. This remains the standard argument against overstating placebo effects.
Any honest placebo library has to include the strongest argument against overstating placebo effects. This is it, and it remains the standard methodological counterweight.
The question
When trials include a genuine no-treatment arm, how much of the improvement attributed to placebo remains?
How it was done
- Systematic review of clinical trials that randomized patients to placebo or to no treatment — the comparison needed to isolate a placebo effect from natural course and regression to the mean.
- 114 trials across a wide range of clinical conditions were included.
- Binary and continuous outcomes were analysed separately.
What was reported
- No significant effect of placebo was found for binary outcomes or for objective continuous outcomes.
- A modest effect appeared for continuous subjective outcomes, particularly pain.
- The authors concluded there was little justification for using placebos outside of trials.
Limitations
- Pooling across very different conditions and outcome types can obscure real effects in specific contexts.
- The analysis predates the open-label placebo literature entirely.
- Later commentary argued that some included trials were not designed to detect placebo effects in the first place.
Why it matters
Much of what circulates publicly about “the power of the placebo” does not survive contact with this paper. It is the reason careful researchers distinguish placebo effects from natural history and regression to the mean.
Citation
Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344(21):1594–1602.
PMID 11372012This summary is written by Efficacy Labs and is not a substitute for the original publication. The research described here is independent work by third parties and was not conducted using Efficacy Labs products. Efficacy Labs products contain no active therapeutic ingredient and are not intended as substitutes for prescribed medication or professional medical care. Information on this website is provided for general educational and research purposes and is not medical advice. References to published research describe independent scientific literature and do not imply that the research was conducted using Efficacy Labs products unless explicitly stated.
Background
What the placebo effect is, explained simply
How the effect is defined, what researchers think drives it, and how it is measured in trials like this one.
Products
Placebo pills for research and education
Inert capsules from Efficacy Labs, what they contain, and how to order them for a study or a classroom.
Continue reading
Randomized controlled trial
Open-label placebo in IBS (2010)
The trial that started modern open-label placebo research: patients were openly told their pills were inert placebos, and were still assessed against a no-treatment control.
Randomized controlled trial
Open-label placebo in chronic low back pain (2016)
An open-label placebo added on top of patients' existing treatment as usual for chronic low back pain, tested over three weeks in Portugal.
Randomized controlled trial
Open-label placebo and cancer-related fatigue (2018)
Cancer survivors with persistent fatigue took openly labelled placebo pills for three weeks alongside their usual care.